{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:22:06Z","timestamp":1773292926017,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:00:00Z","timestamp":1358380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1479-5876-11-18","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T05:15:32Z","timestamp":1358399732000},"source":"Crossref","is-referenced-by-count":45,"title":["The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX\u00ae) in the treatment of inflammatory arthritis"],"prefix":"10.1186","volume":"11","author":[{"given":"Jorge M","family":"Santos","sequence":"first","affiliation":[]},{"given":"Rita N","family":"B\u00e1rcia","sequence":"additional","affiliation":[]},{"given":"Sandra I","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Manuela M","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Calado","sequence":"additional","affiliation":[]},{"given":"Ana","family":"\u00c1gua-Doce","sequence":"additional","affiliation":[]},{"given":"S\u00edlvia CP","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Filipe","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 P","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Gra\u00e7a","sequence":"additional","affiliation":[]},{"given":"Maria EM","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Helder","family":"Cruz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"crossref","first-page":"S09","DOI":"10.18553\/jmcp.2011.17.s9-b.S09","volume":"17","author":"K Farheen","year":"2011","unstructured":"Farheen K, Agarwal SK: Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011, 17: S09-S13.","journal-title":"J Manag Care Pharm"},{"key":"1403_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/ard.2004.024927","volume":"64","author":"M van Oosterhout","year":"2005","unstructured":"van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, van Laar JM: Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann Rheum Dis. 2005, 64: 537-543. 10.1136\/ard.2004.024927.","journal-title":"Ann Rheum Dis"},{"key":"1403_CR3","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar2798","volume":"11","author":"M Nakou","year":"2009","unstructured":"Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT: Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response. Arthritis Res Ther. 2009, 11: R131-10.1186\/ar2798.","journal-title":"Arthritis Res Ther"},{"key":"1403_CR4","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/art.21830","volume":"54","author":"KL Hyrich","year":"2006","unstructured":"Hyrich KL, Symmons DP, Watson KD, Silman AJ: Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology biologics register. Arthritis Rheum. 2006, 54: 1786-1794. 10.1002\/art.21830.","journal-title":"Arthritis Rheum"},{"key":"1403_CR5","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/ar1933","volume":"8","author":"J Listing","year":"2006","unstructured":"Listing J, Strangfeld A, Rau R, Kekow J, Gromnica-Ihle E, Klopsch T, Demary W, Burmester GR, Zink A: Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low\u2013results from RABBIT, the German biologics register. Arthritis Res Ther. 2006, 8: R66-10.1186\/ar1933.","journal-title":"Arthritis Res Ther"},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"e21703","DOI":"10.1371\/journal.pone.0021703","volume":"6","author":"G Moll","year":"2011","unstructured":"Moll G, Jitschin R, von Bahr L, Rasmusson-Duprez I, Sundberg B, Lonnies L, Elgue G, Nilsson-Ekdahl K, Mougiakakos D, Lambris JD: Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses. PLoS One. 2011, 6: e21703-10.1371\/journal.pone.0021703.","journal-title":"PLoS One"},{"key":"1403_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S: Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009, 27: 1421-1432. 10.1002\/stem.68.","journal-title":"Stem Cells"},{"key":"1403_CR8","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005, 106: 1755-1761. 10.1182\/blood-2005-04-1496.","journal-title":"Blood"},{"key":"1403_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007, 25: 1737-1745. 10.1634\/stemcells.2007-0054.","journal-title":"Stem Cells"},{"key":"1403_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcb.21172","volume":"101","author":"J Ringe","year":"2007","unstructured":"Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M: Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007, 101: 135-146. 10.1002\/jcb.21172.","journal-title":"J Cell Biochem"},{"key":"1403_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","volume":"67","author":"E Soleymaninejadian","year":"2012","unstructured":"Soleymaninejadian E, Pramanik K, Samadian E: Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. 2012, 67: 1-8.","journal-title":"Am J Reprod Immunol"},{"key":"1403_CR12","first-page":"S34","volume":"30","author":"E De Miguel","year":"2012","unstructured":"De Miguel E, Roxo A, Castillo C, Peiteado D, Villalba A, Martin-Mola E: The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arthritis. Clin Exp Rheumatol. 2012, 30: S34-S38.","journal-title":"Clin Exp Rheumatol"},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/jgm.452","volume":"5","author":"A Chapel","year":"2003","unstructured":"Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F: Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003, 5: 1028-1038. 10.1002\/jgm.452.","journal-title":"J Gene Med"},{"key":"1403_CR14","doi-asserted-by":"publisher","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"SJ Prasanna","year":"2010","unstructured":"Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB: Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010, 5: e9016-10.1371\/journal.pone.0009016.","journal-title":"PLoS One"},{"key":"1403_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cellimm.2011.11.009","volume":"273","author":"CC Wu","year":"2012","unstructured":"Wu CC, Wu TC, Liu FL, Sytwu HK, Chang DM: TNF-alpha inhibitor reverse the effects of human umbilical cord-derived stem cells on experimental arthritis by increasing immunosuppression. Cell Immunol. 2012, 273: 30-40. 10.1016\/j.cellimm.2011.11.009.","journal-title":"Cell Immunol"},{"key":"1403_CR16","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Yu P: Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2010, 12: R210-10.1186\/ar3187.","journal-title":"Arthritis Res Ther"},{"key":"1403_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/14653249.2011.635853","volume":"14","author":"W Lin","year":"2012","unstructured":"Lin W, Oh SK, Choo AB, George AJ: Activated T-cells modulate immunosuppression by embryonic- and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. Cytotherapy. 2012, 14: 274-284. 10.3109\/14653249.2011.635853.","journal-title":"Cytotherapy"},{"key":"1403_CR18","volume-title":"Isolation method of precursor cells from human umbilical cord","author":"J Santos","year":"2008","unstructured":"Santos J, Soares R, Martins JP, Basto V, Coelho M, Cruz P, Cruz H: INPI ed., vol. 103843. Isolation method of precursor cells from human umbilical cord. 2008, Portugal: Medinfar, ECBio"},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1634\/stemcells.21-1-50","volume":"21","author":"KE Mitchell","year":"2003","unstructured":"Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T: Matrix cells from Wharton\u2019s jelly form neurons and glia. Stem Cells. 2003, 21: 50-60. 10.1634\/stemcells.21-1-50.","journal-title":"Stem Cells"},{"key":"1403_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","volume":"24","author":"ML Weiss","year":"2006","unstructured":"Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of parkinson\u2019s disease. Stem Cells. 2006, 24: 781-792. 10.1634\/stemcells.2005-0330.","journal-title":"Stem Cells"},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"905621","DOI":"10.4061\/2011\/905621","volume":"2011","author":"K Cooper","year":"2011","unstructured":"Cooper K, Viswanathan C: Establishment of a mesenchymal stem cell bank. Stem Cells Int. 2011, 2011: 905621-","journal-title":"Stem Cells Int"},{"key":"1403_CR22","doi-asserted-by":"publisher","first-page":"326813","DOI":"10.1155\/2012\/326813","volume":"2012","author":"A Marmotti","year":"2012","unstructured":"Marmotti A, Mattia S, Bruzzone M, Buttiglieri S, Risso A, Bonasia DE, Blonna D, Castoldi F, Rossi R, Zanini C: Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int. 2012, 2012: 326813-","journal-title":"Stem Cells Int"},{"key":"1403_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1615\/CritRevBiomedEng.v38.i5.10","volume":"38","author":"IA Titushkin","year":"2010","unstructured":"Titushkin IA, Shin J, Cho M: A new perspective for stem-cell mechanobiology: biomechanical control of stem-cell behavior and fate. Crit Rev Biomed Eng. 2010, 38: 393-433. 10.1615\/CritRevBiomedEng.v38.i5.10.","journal-title":"Crit Rev Biomed Eng"},{"key":"1403_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3181\/00379727-111-27849","volume":"111","author":"CA Winter","year":"1962","unstructured":"Winter CA, Risley EA, Nuss GW: Carrageenan-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962, 111: 544-547.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1403_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2004.12.008","volume":"103","author":"SI Simoes","year":"2005","unstructured":"Simoes SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, Cruz ME, Corvo ML, Martins MB: Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in transfersomes. J Control Release. 2005, 103: 419-434. 10.1016\/j.jconrel.2004.12.008.","journal-title":"J Control Release"},{"key":"1403_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2006.10.018","volume":"117","author":"MM Gaspar","year":"2007","unstructured":"Gaspar MM, Boerman OC, Laverman P, Corvo ML, Storm G, Cruz ME: Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J Control Release. 2007, 117: 186-195. 10.1016\/j.jconrel.2006.10.018.","journal-title":"J Control Release"},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1084\/jem.162.3.962","volume":"162","author":"JD Taurog","year":"1985","unstructured":"Taurog JD, Kerwar SS, McReynolds RA, Sandberg GP, Leary SL, Mahowald ML: Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med. 1985, 162: 962-978. 10.1084\/jem.162.3.962.","journal-title":"J Exp Med"},{"key":"1403_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2567.2008.02813.x","volume":"124","author":"DK Sojka","year":"2008","unstructured":"Sojka DK, Huang YH, Fowell DJ: Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology. 2008, 124: 13-22. 10.1111\/j.1365-2567.2008.02813.x.","journal-title":"Immunology"},{"key":"1403_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR: Interleukin-17-producing T-cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T-cell numbers. Arthritis Rheum. 2008, 58: 875-887. 10.1002\/art.23291.","journal-title":"Arthritis Rheum"},{"key":"1403_CR30","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/eji.200526303","volume":"35","author":"L Graca","year":"2005","unstructured":"Graca L: New tools to identify regulatory T-cells. Eur J Immunol. 2005, 35: 1678-1680. 10.1002\/eji.200526303.","journal-title":"Eur J Immunol"},{"key":"1403_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/eji.201040896","volume":"41","author":"VG Oliveira","year":"2011","unstructured":"Oliveira VG, Caridade M, Paiva RS, Demengeot J, Graca L: Sub-optimal CD4+ T-cell activation triggers autonomous TGF-beta-dependent conversion to Foxp3+ regulatory T-cells. Eur J Immunol. 2011, 41: 1249-1255. 10.1002\/eji.201040896.","journal-title":"Eur J Immunol"},{"key":"1403_CR32","doi-asserted-by":"publisher","first-page":"e10558","DOI":"10.1371\/journal.pone.0010558","volume":"5","author":"J Duarte","year":"2010","unstructured":"Duarte J, Agua-Doce A, Oliveira VG, Fonseca JE, Graca L: Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PLoS One. 2010, 5: e10558-10.1371\/journal.pone.0010558.","journal-title":"PLoS One"},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.4049\/jimmunol.1201269","volume":"189","author":"J Duarte","year":"2012","unstructured":"Duarte J, Carrie N, Oliveira VG, Almeida C, Agua-Doce A, Rodrigues L, Simas JP, Mars LT, Graca L: T-cell apoptosis and induction of Foxp3+ regulatory T-cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis. J Immunol. 2012, 189: 1680-1688. 10.4049\/jimmunol.1201269.","journal-title":"J Immunol"},{"key":"1403_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8: 315-317. 10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"1403_CR35","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1136\/annrheumdis-2011-200985","volume":"71","author":"A Papadopoulou","year":"2012","unstructured":"Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I, Fassas A, Anagnostopoulos A, Yannaki E: Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis. 2012, 71: 1733-1740. 10.1136\/annrheumdis-2011-200985.","journal-title":"Ann Rheum Dis"},{"key":"1403_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L: Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007, 84: 231-237. 10.1097\/01.tp.0000267918.07906.08.","journal-title":"Transplantation"},{"key":"1403_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"NG Singer","year":"2011","unstructured":"Singer NG, Caplan AI: Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011, 6: 457-478. 10.1146\/annurev-pathol-011110-130230.","journal-title":"Annu Rev Pathol"},{"key":"1403_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/ar1745","volume":"7","author":"M Londei","year":"2005","unstructured":"Londei M: Role of regulatory T-cells in experimental arthritis and implications for clinical use. Arthritis Res Ther. 2005, 7: 118-120. 10.1186\/ar1745.","journal-title":"Arthritis Res Ther"},{"key":"1403_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","volume":"4","author":"Q Lan","year":"2012","unstructured":"Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG: Induced Foxp3(+) regulatory T-cells: a potential new weapon to treat autoimmune and inflammatory diseases?. J Mol Cell Biol. 2012, 4: 22-28. 10.1093\/jmcb\/mjr039.","journal-title":"J Mol Cell Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-11-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T03:24:55Z","timestamp":1644117895000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-18","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]},"article-number":"18"}}